Skip to main content
. 2022 Apr 22;12(3):453–462. doi: 10.1177/19418744221083182

Table 1.

Patient characteristics before and after neurohospitalist intervention.

  Intervention (neurohospitalist) Control (stroke)
Pre (n = 1121) Post (n = 527) SMD a P-value Pre (n = 717) Post (n = 341) SMD a P-value
Age (%), y
Median [IQR] 50 [34, 66] 56 [38, 69] .18 .001 75 [62, 84] 74 [60, 85] .05 .52
Male, % 492 (43.9) 262 (49.7) .12 .03 366 (51.0) 165 (48.4) .05 .46
Primary insurance (%) .31 <.001 .28 <.001
Medicare 363 (32.4) 218 (41.4) 467 (65.1) 213 (62.5)
Medicaid/Medi-Cal 167 (14.9) 84 (15.9) 58 (8.1) 52 (15.2)
Private 525 (46.8) 219 (41.6) 163 (22.7) 72 (21.1)
Other 66 (5.9) 6 (1.1) 29 (4.0) 4 (1.2)
Charlson Comorbidity Index .38 <.001 .79 <.001
0 (none) 668 (59.6) 227 (43.1) 4 (.6) 5 (1.5)
1-2 (mild) 330 (29.4) 185 (35.1) 478 (66.7) 103 (30.2)
3-4 (moderate) 80 (7.1) 69 (13.1) 171 (23.8) 165 (48.4)
>=5 (severe) 43 (3.8) 46 (8.7) 64 (8.9) 68 (19.9)
Median [IQR] 0 [0,1] 1 [0, 2] .35 <.001 2 [1, 3] 3 [2, 4] .66 <.001
Top DRG b (%) .42 <.001 .86 <.001
Seizures 188 (16.8) 96 (18.2)
Degenerative disorders 80 (7.1) 60 (11.4)
Nonbacterial CNS infections excluding viral meningitis 46 (4.1) 52 (9.9)
Nervous system neoplasms 81 (7.2) 41 (7.8)
MS or Cerebellar ataxia 75 (6.7) 27 (5.1)
Other diseases of nervous system 52 (4.6) 27 (5.1)
Bacterial Tb of nervous system 49 (4.4) 25 (4.7)
Neurologic eye disease 37 (3.3) 24 (4.6)
Cranial or Peripheral nerve 47 (4.2) 20 (3.8)
Headache 115 (10.3) 17 (3.2)
ICH or stroke 639 (89.1) 269 (78.9)
Acute stroke with thrombolytic 8 (1.1) 32 (9.4)
TIA 40 (5.6) 10 (2.9)
Case Mix Index (CMI)
Mean (sd) 1.1 (.6) 1.4 (.9) .43 <.001 1.1 (.4) 1.4 (.5) .60 <.001
APR DRG (%) .46 <.001 .58 <.001
Extreme 34 (3.0) 46 (8.7) 22 (3.1) 40 (11.7)
Major 270 (24.1) 199 (37.8) 191 (26.6) 128 (37.5)
Moderate 510 (45.5) 202 (38.3) 379 (52.9) 159 (46.6)
Minor 302 (26.9) 78 (14.8) 119 (16.6) 14 (4.1)
Missing 5 (.4) 2 (.4) 6 (.8) 0 (.0)
Weight, mean (sd) .9 (.7) 1.0 (.8) .21 <.001 1.0 (.4) 1.2 (.6) .46 <.001
Admission source (%) .42 <.001 .24 .006
Hospital transfers 193 (17.2) 92 (17.5) 105 (14.6) 73 (21.4)
Emergency/trauma 700 (62.4) 400 (75.9) 592 (82.6) 288 (78.0)
Clinic/direct admit 225 (20.1) 35 (6.6) 18 (2.5) 2 (.6)
Other 3 (.3) 0 (.0) 2 (.3) 0 (.0)
Discharge disposition (%) .37 <.001 .43 <.001
Home (routine/with care) 889 (79.3) 337 (63.9) 471 (65.7) 162 (47.5)
Other acute care facility/hospital 97 (8.7) 88 (16.7) 74 (10.3) 77 (22.6)
Skilled nursing facility (SNF) 93 (8.3) 79 (15.6) 116 (16.2) 71(20.8)
Hospice 30 (2.7) 20 (3.8) 31 (4.3) 22 (6.5)
In-hospital death 4 (.4) 2 (.4) 17 (2.4) 7 (2.1)

SMD: standardized mean difference; IQR: interquartile range; DRG: diagnosis-related group, CNS: central nervous system; MS: multiple sclerosis; Tb: tuberculosis; ICH: intracranial hemorrhage; APR-DRG: 3M™ All Patients Refined Diagnosis-Related Groups; SNF: skilled nursing facility.

aThe higher the SMD, the greater the magnitude of difference between the two groups. Cohen offered the following guidelines for interpreting the magnitude of the SMD: small, SMD = .2; medium, SMD = .5; and large, SMD = .8.19,20

bRepresentative diagnoses include (see Table e-1): Degenerative disorders—myasthenia gravis, amyotrophic lateral sclerosis, Parkinson’s disease, Alzheimer’s dementia, and dementia with Lewy bodies; nonbacterial CNS infections—viral encephalitis, fungal meningitis, acute disseminated encephalomyelitis, transverse myelitis, and autoimmune encephalitis; bacterial Tb of the nervous system—Guillain-Barre syndrome and intracranial abscess